Original contributionEffect of EFONIDIPINE (cas 111011-63-3) and ACE inhibitors on proteinuria in human hypertension with renal impairment
-
Add time:08/29/2019 Source:sciencedirect.com
BackgroundAlthough several lines of recent studies fail to demonstrate the beneficial action of calcium antagonists, a novel dihydropyridine EFONIDIPINE (cas 111011-63-3), which possesses dilatory action of both afferent and efferent arterioles and, therefore, shares the renal microvascular action with angiotensin converting enzyme (ACE) inhibitors, is reported to exhibit renal protection in experimental animals.
We also recommend Trading Suppliers and Manufacturers of EFONIDIPINE (cas 111011-63-3). Pls Click Website Link as below: cas 111011-63-3 suppliers
Prev:Full PaperEffect of EFONIDIPINE (cas 111011-63-3) on TGF-β1–Induced Cardiac Fibrosis Through Smad2-Dependent Pathway in Rat Cardiac Fibroblasts
Next:Short CommunicationSpecies Difference in the Contribution of T-Type Calcium Current to Cardiac Pacemaking as Revealed by R(−)-EFONIDIPINE (cas 111011-63-3)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short CommunicationSpecies Difference in the Contribution of T-Type Calcium Current to Cardiac Pacemaking as Revealed by R(−)-EFONIDIPINE (cas 111011-63-3)08/30/2019
- Full PaperEffect of EFONIDIPINE (cas 111011-63-3) on TGF-β1–Induced Cardiac Fibrosis Through Smad2-Dependent Pathway in Rat Cardiac Fibroblasts08/28/2019
- Cardiovascular PharmacologyEffects of S(+)-EFONIDIPINE (cas 111011-63-3) on the rabbit sinus node action potential and calcium channel subunits CaV1.2, CaV1.3 and CaV3.108/27/2019
- Effects of the iron chelator deferiprone and the T-type calcium channel blocker EFONIDIPINE (cas 111011-63-3) on cardiac function and Ca2+ regulation in iron-overloaded thalassemic mice08/26/2019
- The Ca2 + channel inhibitor EFONIDIPINE (cas 111011-63-3) decreases voltage-dependent K+ channel activity in rabbit coronary arterial smooth muscle cells08/25/2019
- A chiral LC–MS/MS method for the stereospecific determination of EFONIDIPINE (cas 111011-63-3) in human plasma08/24/2019
- Determination of EFONIDIPINE (cas 111011-63-3) in human plasma by LC–MS/MS for pharmacokinetic applications08/23/2019
- Research paperIncreased bioavailability of EFONIDIPINE (cas 111011-63-3) hydrochloride nanosuspensions by the wet-milling method08/22/2019
